These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA. Science; 2001 Aug 10; 293(5532):1155-9. PubMed ID: 11498595 [Abstract] [Full Text] [Related]
5. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association. Maerz AL, Drummer HE, Wilson KA, Poumbourios P. J Virol; 2001 Jul 10; 75(14):6635-44. PubMed ID: 11413331 [Abstract] [Full Text] [Related]
6. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs. Prabakaran P, Gan J, Wu YQ, Zhang MY, Dimitrov DS, Ji X. J Mol Biol; 2006 Mar 17; 357(1):82-99. PubMed ID: 16426633 [Abstract] [Full Text] [Related]
8. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein. Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T. Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203 [Abstract] [Full Text] [Related]
9. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, Sodroski J. Nature; 1996 Nov 14; 384(6605):179-83. PubMed ID: 8906795 [Abstract] [Full Text] [Related]